Myomo Announces Pricing of $6.5 Million Upsized Public Offering

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its “best efforts” public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.325 per share for aggregate gross proceeds of approximately $6.5 million, before deducting placement agent fees and other offering expenses. The closing of the offering is expected to occur on or about January 17, 2023, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. Members of management, affiliated investors and certain high-quality healthcare focused investors are participating in this offering. Read more >>